Nucor Corporation
NYSE:NUESteel
-$8.78 today
- Market cap
- $56.33B
- Beta
- 1.91
- P/E (TTM)
- 23.9
- EPS (TTM)
- $10.18
- Dividend yield
- 0.91%
Volume 1.14M
Average 1.50M
NUE EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Nucor CorporationNYSE: NUE
EBITDA · Q3 FY2026 · quarter ended Sep 2026
EBITDA remains negative
Q3 FY2026 EBITDA was $0, compared with $1.29B a year earlier. Trailing-twelve-month EBITDA was $4.48B. Over 3 fiscal years it compounded at -28.6% a year.
Context
- EBITDA amounted to 13.0% of revenue in FY2025, down 1.6 pp from a year earlier.
- EBITDA increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 9 analysts of $8.31B (+97.0%) for the fiscal year ending Dec 2026, a step up from the -6.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $0-100.0% QoQ
- Last fiscal yearDec 2025
- $4.22B-6.0% YoY
- LTMSep 2026
- $4.48B+9.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -100.0% | +155.9% | +255.9 pp |
| 1 year | -6.0% | +97.0% | +103.0 pp |
| 3-year CAGR | -28.6% | +27.0% | +55.5 pp |
| 5-year CAGR | +15.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 4.22B USD
- Year-over-year change
- -6.0%
- 4-year CAGR
- -19.9%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.22B | -6.0% |
| FY2024 | 2024-12-31 | 4.49B | -41.6% |
| FY2023 | 2023-12-31 | 7.69B | -33.5% |
| FY2022 | 2022-12-30 | 11.57B | +13.1% |
| FY2021 | 2021-12-31 | 10.23B | — |
EBITDA vs competitors
How NUE compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +9.0% is the 5th highest of 9, against a peer median of +21.5%.
- EBITDA amounts to 11.5% of revenue for NUE, versus a peer median of 13.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $8.03B USD | +41.9% | -25.4% | 12.8% | |
| LTM Mar 2026 | R$6.1B BRL | -17.4% | -11.4% | 13.7% | |
| LTM Sep 2026 | $4.48B USD | +9.0% | -28.6% | 11.5% | |
| LTM Sep 2026 | $3.5B USD | +73.7% | -27.3% | 15.7% | |
| LTM Jun 2026 | $1.94B USD | +1.1% | -23.1% | 12.2% | |
| LTM Aug 2026 | $1.25B USD | +184.9% | -3.3% | 13.3% | |
| LTM Sep 2026 | $985M USD | +399.4% | — | 4.9% | |
| LTM Aug 2026 | $224.8M USD | -6.9% | -1.9% | 4.2% | |
| LTM Mar 2026 | -CA$496.9M CAD | -659.0% | — | 26.6% | |
| Peer median (excluding NUE) | — | +21.5% | -17.3% | 13.0% | |
Competitors are the stored peer set for NUE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 36.48B | 41.51B | 34.71B | 30.73B | 32.49B |
| Cost of Revenue | 25.46B | 29.01B | 26.9B | 26.63B | 28.62B |
| Gross Profit | 11.03B | 12.5B | 7.82B | 4.1B | 3.88B |
| Gross Margin | 30.2% | 30.1% | 22.5% | 13.3% | 11.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.71B | 2B | 1.59B | 1.12B | 1.22B |
| Operating Expenses | 1.71B | 2B | 1.59B | 1.12B | 1.22B |
| Depreciation & Amortization | 864.56M | 1.06B | 1.17B | 1.36B | 1.48B |
| EBITDA | 10.23B | 11.57B | 7.69B | 4.49B | 4.22B |
| EBITDA Margin | 28.0% | 27.9% | 22.1% | 14.6% | 13.0% |
| Operating Income | 9.32B | 10.51B | 6.23B | 2.98B | 2.66B |
| Operating Margin | 25.5% | 25.3% | 17.9% | 9.7% | 8.2% |
| Interest Income | 4.27M | 48.7M | 276M | 258M | 111M |
| Interest Expense | 163.12M | 218.91M | 246M | 228M | 170M |
| Other Income / Expenses | (117.95M) | (261M) | 43M | (77M) | (91M) |
| Income Before Tax | 9.2B | 10.25B | 6.27B | 2.9B | 2.57B |
| Pre-Tax Margin | 25.2% | 24.7% | 18.1% | 9.4% | 7.9% |
| Income Tax Expense | 2.08B | 2.17B | 1.36B | 583M | 530M |
| Net Income | 6.83B | 7.61B | 4.52B | 2.03B | 1.74B |
| Net Margin | 18.7% | 18.3% | 13.0% | 6.6% | 5.4% |
| EPS (Basic) | 23.23 | 28.88 | 18.05 | 8.47 | 7.53 |
| EPS (Diluted) | 23.16 | 28.79 | 18.00 | 8.46 | 7.52 |
| Weighted Avg Shares | 292.49M | 262.35M | 249.77M | 238.3M | 230.7M |
| Weighted Avg Shares (Diluted) | 293.39M | 263.18M | 250.41M | 238.5M | 230.9M |
Nucor Corporation
NYSE:NUE
Intrinsic Alpha fair value
Locked
Current Price
$250.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.